United States · FDA National Drug Code directory

Lansoprazole

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 0378-6982_00959575-41db-4810-b59c-1edd08568b17
Product NDC: 0378-6982
Form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
Composition / generic term: lansoprazole
Labeler: Mylan Pharmaceuticals Inc.
Marketing category: ANDA
Marketing start / end (source format): 20181129
Source listing expiry: 20261231

Source-listed ingredients

LANSOPRAZOLE — 30 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

2 CARTON in 1 BOX (0378-6982-88) / 5 BLISTER PACK in 1 CARTON (0378-6982-85) / 10 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK (0378-6982-32) · 0378-6982-88

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →